Estrogens and benign prostatic hyperplasia: rationale for therapy with aromatase inhibitors.
Henderson
D
D
D000735:Androstenedione / Q000031:analogs & derivatives / Q000627:therapeutic use; D000818:Animals; D047072:Aromatase Inhibitors; D004967:Estrogens / Q000502:physiology*; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000503:physiopathology
D047072:Aromatase Inhibitors; D004967:Estrogens; D000735:Androstenedione; C048751:atamestane; C014594:formestane